Pregnancy and uterine fibroids (leiomyoma): a critical review
https://doi.org/10.23946/2500-0764-2023-8-3-107-115
Abstract
Here we review current opportunities in pregnancy management in women with uterine fibroids, also known as leiomyoma. Uterine fibroids are associated with a number of complications already at planning for pregnancy and also during pregnancy and labour. We discuss vaginal delivery and caesarian section in such patients, considering safety issue with regards to myomectomy and its expediency before pregnancy and during caesarean section. Multiple controversies and debates emphasize the need for the further research in this direction.
About the Authors
I. F. Fatkullin
Kazan Medical University
Russian Federation
Russian Federation
Ildar F. Fatkullin - MD, DSc, Professor, Head of the Department of Obstetrics and Gynecology, Kazan Medical University.
49, Butlerova Street, Kazan, 420012
Yu. V. Orlov
Kazan Medical University
Russian Federation
Russian Federation
Yuriy V. Orlov - MD, PhD, Head of the Accreditation and Simulation Center, Associate Professor, Department of Obstetrics and Gynecology, Kazan Medical University.
49, Butlerova Street, Kazan, 420012
L. S. Fatkullina
Kazan Medical University
Russian Federation
Russian Federation
Larisa S. Fatkullina - MD, PhD, Associate Professor, Department of Obstetrics and Gynecology, Kazan Medical University.
49, Butlerova Street, Kazan, 420012
V. V. Korennaya
Russian Medical Academy of Continuous Professional Education
Russian Federation
Russian Federation
Vera V. Korennaya - MD, PhD, Associate Professor, Department of Obstetrics and Gynecology, Russian Medical Academy of Continuing Professional Education.
Building 1, 2/1, Barrikadnaya Street, Moscow, 125993
References
1. Chill H.H., Karavani G., Rachmani T., Dior U., Tadmor O., Shushan A. Growth pattern of uterine leiomyoma along pregnancy. BMC Women's Health. 2019;19(1):100. https://doi.org/10.1186/s12905-019-0803-5
2. Fatkullin IF, Bakanova AR, Ilizarova NA, Galeev AA. New possibilities of treatment of uterine fibroids in women with reproductive dysfunction. Doctor. Ru. 2016; 8-9(125-126):32-37. (In Russ).
3. Pecout M., Cosson M., Collinet P., Rubod C., Giraudet G. Disappearance of a myoma after pregnancy in a 38 years old patient, treated by ulipristal acetate without success before getting pregnant. J. Gynecol. Obstet. Hum. Reprod. 2019;48(9):781-783. https://doi.org/10.1016/j.jogoh.2019.03.015
4. Baird D.D., Patchel S.A., Saldana T.M., Umbach D.M., Cooper T., Wegienka G., Harmon Q.E. Uterine fibroid incidence and growth in an ultrasound-based, prospective study of young African Americans. Am. J. Obstet. Gynecol. 2020;223(3):402.e1-402.e18. https://doi.org/10.1016/j.ajog.2020.02.016
5. Sohn G.S., Cho S., Kim Y.M., Cho C.H., Kim M.R., Lee S.R.; Working Group of Society of Uterine Leiomyoma. Current medical treatment of uterine fibroids. Obstet. Gynecol. Sci. 2018;61(2):192-201. https://doi.org/10.5468/ogs.2018.61.2.192
6. Giuliani E., As-Sanie S., Marsh E.E. Epidemiology and management of uterine fibroids. Int. J. Gynaecol. Obstet. 2020;149(1):3-9. https://doi.org/10.1002/ijgo.13102
7. Korotkih IN, Lapteva TN, Kuranosova IYu. Analysis of risk factors affecting the complicated course of pregnancy and birth outcomes in women with uterine myoma. System analysis and management in biomedical systems. 2019;18(1):40-44. (In Russ). https://doi.org/10.25987/VSTU.2019.18.1.006
8. Krimou Y., Erraghay S., Guennoun A., Mamouni N., Bouchikhi C., Banani A. Myoma praevia and pregnancy. Pan. Afr. Med. J. 2019;33:216. https://doi.org/10.11604/pamj.2019.33.216.1489
9. Abdullah R.K., Massey I.Y., Liu N., Zhao Y., Zeng H. The differences in characteristics of uterine leiomyomas and the diverse adverse pregnancy outcomes. J. Obstet. Gynaecol. 2021;41(6):841-847. https://doi.org/10.1080/01443615.2020.1846020
10. Vitagliano A., Noventa M., Di Spiezio Sardo A., Saccone G., Gizzo S., Borgato S., Vitale S.G., Lagana A.S., Nardelli G.B., Litta P.S., Saccardi C. Uterine fibroid size modifications during pregnancy and puerperium: evidence from the first systematic review of literature. Arch. Gynecol. Obstet. 2018;297(4):823-835. https://doi.org/10.1007/s00404-017-4621-4
11. Amangeldy LB, Rymzhanova AZ, Kojshybaeva NS. Uterine myoma and pregnancy. Eurasian Scientific Association. 2021;(2-3):141-142. (In Russ).
12. Kulakov VI, Shmakov GS. Miomjektomija i beremennost'. Moscow : Med-pressinform; 2001. (In Russ.)
13. .Milazzo G.N., Catalano A., Badia V., Mallozzi M., Caserta D. Myoma and myomectomy: Poor evidence concern in pregnancy. J. Obstet. Gynaecol. Res. 2017;43:1789-1804. https://doi.org/10.1111/jog.13437
14. Parazzini F., Gerli S., Bianchi S., Chiaffarino F., Favilli A. The Global Library of Women's Medicine Clinical guidance and resourses. In: Pregnancy complaints and complications: clinical presentations. 2021. Vol. 6: 1756-2228.
15. Cagan M., Tanacan А., Donmez H.G., Fadiloglu Е., Unal C., Beksac M.S. The Effect of Small Size Uterine Fibroids on Pregnancy Outcomes in High-risk Pregnancies. Rev. Bras. Ginecol. Obstet. 2020;42(9):535-539. https://doi.org/10.1055/s-0040-1713913
16. Borghese G., Raffone A., Raimondo D., Saccone G., Travaglino A., Esposti E.D., Mastronardi M., Salucci P., Zullo F., Seracchioli R. Adhesion barriers in laparoscopic myomectomy: Evidence from randomized clinical trials. Int. J. Gynaecol. Obstet. 2021;152(3):308-320. https://doi.org/10.1002/ijgo.13495
17. Lasmar R.B., Lasmar B.P., Moawad N.S. Hysteroscopic myomectomy. Medicina. 2022;58(11):1627. https://doi.org/10.3390/medicina58111627
18. Dobrokhotova IuE, Danelian SZh, Borovkova EI, Nagaitseva EA, Sarakhova DKh, Selimshaeva DS, Borovskaia KA. Pregnancy management in patients with uterine fibroids. Case report. Gynecology. 2021;23(2):448-453. (In Russ). https://doi.org/10.26442/20795696.2021.5.200777
19. Buyanova SN, Yudina NV, Gukasyan SA, Ermolaeva EE. Indications for myomectomy during pregnancy and outcomes. Obstetrics and Gynecology. 2019;6:70-77. (In Russ). https://doi.org/10.18565/aig.2019.6.70-77
20. Barinov SV, Chulovskij YuI, Mozgovoj SI, Shamina IV, Ledovskih IO, Frikel' EA. Experience in the Management of Pregnant Women in the Second Trimester with Large Uterine Myoma. Russian Bulletin of Obstetrician-Gynecologist. 2020;20(5):54-60. (In Russ). https://doi.org/10.17116/rosakush20202005154
21. Timokhina EV, Gubanova EV, Silayeva TM. Pregnancy with uterine myoma and after myomectomy: results of the cohort study. Archives of Obstetrics and Gynecology. 2019;6(3):132-139. (In Russ). https://doi.org/10.18821/2313-8726-2019-6-3-132-139
22. Kuharchik JuV, Gutikova LV, Kolesnikova TA. Techenie beremennosti i rodov u zhenshhin s miomoj matki. In: Sovremennye perinatal'nye medicinskie tehnologii v reshenii problem demograficheskoj bezopasnosti: sbornik nauchnyh trudov. Minsk: RNMB; 2017. (In Russ). Available at: http://rep.med.by/handle/data/189. Accessed May 14, 2023.
23. Lethaby A., Duckitt K., Farquhar C. Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding. Cochrane database of systematic reviews. Version published: 2019 Sep. 19:CD000400 https://doi.org/10.1002/14651858.CD000400.pub4
24. Claeys J., Hellendoorn I., Hamerlynck T., Bosteels J., Weyers S. The risk of uterine rupture after myomectomy: a systematic review of the literature and meta-analysis. Gynecol Surg. 2014;11:197-206. https://doi.org/10.1007/s10397-014-0842-8
25. Lee S.J., Ko H.S., Na S., Bae J.Y., Seong W.J. Kim J.W., Shin J., Cho H.J., Choi G.Y., Kim J., Cho G.J., Park I.Y. Nationwide population-based cohort study of adverse obstetric outcomes in pregnancies with myoma or following myomectomy: retrospective cohort study. BMC Pregnancy Childbirth. 2020;20(1):716. https://doi.org/10.1186/s12884-020-03406-9
26. Goyal M., Dawood A.S., Elbohoty S.B., Abbas A.M., Singh P., Melana N., Singh S. Cesarean myomectomy in the last ten years; A true shift from contraindication to indication: A systematic review and meta-analysis. Eur. J. Obstet. Gynecol. Reprod. Biol. 2021;256:145-157. https://doi.org/10.1016/j.ejogrb.2020.11.008
27. Tirnovanu M.C., Lozneanu L., Tirnovanu Ş.D., Tirnovanu V.G., Onofriescu M., Ungureanu C., Toma B.F., Cojocaru E. Uterine Fibroids and Pregnancy: A Review of the Challenges from a Romanian Tertiary Level Institution. Healthcare (Basel). 2022;10(5):855. https://doi.org/10.3390/healthcare10050855
28. Huang Y., Ming X., Li Z. Feasibility and safety of performing cesarean myomectomy: a systematic review and meta-analysis. J. Matern. Fetal Neonatal. Med. 2022;35(13):2619-2627. https://doi.org/10.1080/14767058.2020.1791816
29. Kim M.J., Lee K., Park J.Y., Jo J.H., Park I.Y. The trend in cesarean myomectomies and the risk of obstetrical complications in Korea. BMC Pregnancy Childbirth. 2022;22(1):387. https://doi.org/10.1186/s12884-022-04674-3
30. Jaiswar S.P., Srivastava P., Priyadarshini A., Deo S., Shankhwar P. Safety of cesarean myomectomy with huge myoma compared with uncomplicated cesarean section in Indian scenario. Int. J. Reprod. Contracept Obstet. Gynecol. 2015;4(6):1696-1699. https://doi.org/10.18203/2320-1770.ijrcog20151127
31. Li H., Du J., Jin L., Shi Z., Liu M. Myomectomy during cesarean section. Acta Obstet. Gyneco.l Scand. 2009;88(2):183-186. https://doi.org/10.1080/00016340802635526
32. Sei K., Masui K., Sasa I., Furuya K. Size of uterine leiomyoma is a predictor for massive haemorrhage during caesarean delivery. Eur. J. Obstet. Gynecol. Reprod. Biol. 2018;223:60-63. https://doi.org/10.1016/j.fertnstert.2010.03.035
33. Carpini G.D., Morini S., Papiccio M., Serri M., Damiani V., Grelloni C., Clemente N., Ciavattini A. The association between childbirth, breastfeeding, and uterine fbroids: an observational study. Sci. Rep. 2019;9(1):10117. https://doi.org/10.1038/s41598-019-46513-0
34. Orlando M., Kollikonda S., Hackett L., Kho R. Non-hysteroscopic Myomectomy and Fertility Outcomes: A Systematic Review. J. Minim. Invasive Gynecol. 2021; 28(3):598-618.e1. https://doi.org/10.1016/j.jmig.2020.10.006
35. Radzinskiy VE, Ordiyants IM, Khorol'skiy VA. Lechenie miomy: variativnost' kak problema. Sravnitel'naya effektivnost' i bezopasnost' dvukh skhem mifepristona dlya medikamentoznoy terapii miomy matki. StatusPraesens. Ginekologiya, akusherstvo, besplodnyy brak. 2015;3(26):39-45. (In Russ).
36. Practice Committee of the American Society for Reproductive Medicine. Removal of myomas in asymptomatic patients to improve fertility and/or reduce miscarriage rate: a guideline. Fertil Steril. 2017;108(3):416-425. https://doi.org/10.1016/j.fertnstert.2017.06.034
37. Yang Q., Ciebiera M., Bariani M.V., Ali M., Elkafas H., Boyer T.G., Al-Hendy A. Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment. Endocr. Rev. 2022;43(4):678-719. https://doi.org/10.1210/endrev/bnab039
38. Rezk A., Kahn J., Singh M. Fertility Sparing Management In Uterine Fibroids. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022. PMID: 34662018
39. Datir S.G., Bhake A. Management of Uterine Fibroids and Its Complications During Pregnancy: A Review of Literature. Cureus. 2022;14(11):e31080. https://doi.org/10.7759/cureus.31080
40. Coutinho L.M., Assis W.A., Spagnuolo-Souza A., Reis F.M. Uterine Fibroids and Pregnancy: How Do They Affect Each Other? Reprod. Sci. 2022;29(8):2145-2151. https://doi.org/10.1007/s43032-021-00656-6
Review
For citations:
Fatkullin I.F., Orlov Yu.V., Fatkullina L.S., Korennaya V.V. Pregnancy and uterine fibroids (leiomyoma): a critical review. Fundamental and Clinical Medicine. 2023;8(3):107-115. (In Russ.) https://doi.org/10.23946/2500-0764-2023-8-3-107-115
Views:
398
Email this article 